01Purpose and principlesWhat the assessment is for and the core concepts behind it.
The first investigation in recurrent UTI is often reconstruction of the history. Several antibiotic prescriptions do not necessarily represent several bacterial infections: dysuria can arise from urethritis, genitourinary menopausal symptoms, bladder pain or other pathology, and a positive culture can represent asymptomatic bacteriuria. Establish which episodes had attributable symptoms, which cultures were taken before treatment and whether there was genuine recovery between episodes.
Once recurrence is confirmed, testing should address the likely reason. A low-risk person with separate episodes of uncomplicated lower infection may not need extensive imaging, whereas repeated upper infections, stone clues, persistent haematuria or impaired emptying change the investigation plan. Prevention is then chosen through shared decision-making, considering symptom burden, susceptibility, pregnancy potential, renal and hepatic safety and previous measures. The aim is fewer symptomatic episodes and less harm, not an indefinitely sterile urine report.
Key points
- Recurrent UTI generally means at least two episodes in six months or three in twelve months; confirm that the episodes were symptomatic infections.
- Compare culture organisms, susceptibility, treatment and symptom-free intervals to distinguish likely relapse from separate reinfections.
- Investigate an indicated contributor such as poor emptying, stones or obstruction; routine cystoscopy and extensive imaging have low yield in otherwise typical uncomplicated recurrent cystitis.
- Seek specialist advice for recurrent infection in male urinary anatomy, recurrent upper UTI, pregnancy, or recurrent lower UTI whose underlying cause is unknown.
- Treat any current infection and address modifiable contributors before deciding whether vaginal oestrogen, trigger prophylaxis, methenamine or daily antibiotic prophylaxis is appropriate.
- Methenamine hippurate 1 g orally twice daily is a preventive option for eligible nonpregnant adult women; it is not a substitute for treating acute pyelonephritis or urosepsis.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Record dates, symptoms, culture findings and response for each episode. Two infections in six months or three in a year meets the usual recurrence definition, but the quality of the episode evidence still matters.
Recurrence with a similar organism soon after apparent treatment may suggest a persistent reservoir, while a different organism or longer symptom-free interval may suggest reinfection. Routine species and susceptibility data cannot prove strain identity.
Upper tract episodes, colicky pain, repeated urease-producing organisms, significant voiding symptoms, persistent haematuria or renal dysfunction point towards a specific underlying problem. Active fever with obstruction signs requires urgent care before an elective recurrent-UTI workup.
Ask about urinary anatomy, pregnancy, menopause, sexual triggers, diabetes, immunosuppression and devices. Vaginal symptoms, discharge or pain without bacterial evidence can redirect the assessment and prevent unhelpful prophylaxis.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Episode and culture chronologyFirst step - Why
- Confirm infection and identify a pattern that changes the workup.
- Interpretation and limitations
- Build a table of symptom dates, organisms, susceptibility, antibiotics and response. A short interval with recurring similar isolates supports looking for persistence; repeated mixed-growth samples call for specimen-quality review before labelling recurrent bacterial infection.
- 02
Postvoid residual when emptying is suspect - Why
- Assess whether incomplete emptying contributes to repeated infection.
- Interpretation and limitations
- Poor stream, incomplete emptying, palpable bladder or relevant neurological disease can justify a postvoid scan. Interpret the measured residual in context and repeat when necessary; no universal single volume diagnoses the mechanism or determines treatment for every patient. An antibiotic-prevention trial or a prostate-reservoir investigation should not postpone this specific emptying assessment when voiding symptoms and postvoid fullness are already present.
- 03
Targeted renal and bladder imaging - Why
- Look for a remediable structural contributor when indicated.
- Interpretation and limitations
- Ultrasound can assess dilation, stones and bladder findings, with CT selected for the specific question. Recurrent upper infection, stone symptoms or a persistent urease-producing organism increases the value of imaging; do not perform the same scan package for every uncomplicated recurrence.
- 04
Selective specialist and lower tract assessment - Why
- Investigate features that routine cultures cannot explain.
- Interpretation and limitations
- Refer according to NG112 for male recurrent infection, recurrent upper infection, pregnancy or lower recurrence with an unknown cause. Cystoscopy is reserved for an indicated concern such as suspected malignancy or atypical pathology, with persistent haematuria assessed through the relevant pathway.
04Clinical next stepsHow the result changes management or prompts escalation.
01Worked caseIdentify impaired bladder emptyingFirst stepA sixty two year old woman has three culture-confirmed lower infections in six months.+
- 1The record shows separate symptomatic Escherichia coli episodes with temporary recovery. She also describes a weak stream and incomplete emptying. A postvoid scan is therefore arranged rather than automatically ordering cystoscopy; she has no fever or current systemic illness, and recurrent-infection referral is organised.
- 2The residual is repeatedly about 280 ml, with no hydronephrosis and preserved renal function. Urological assessment confirms clinically important emptying dysfunction. The team addresses the residual with a supervised intermittent catheterisation plan and teaches technique, while treating any active infection on its own culture-guided merits.
- 3At follow-up she can carry out the agreed emptying plan and no longer experiences persistent bladder fullness. Residual and drained-volume review confirms more reliable emptying; this verification is more informative than prescribing preventive antibiotics without checking the contributor.
- 4Over the next four months she has no further symptomatic infection. The team continues reviewing the emptying strategy and catheter burden rather than claiming permanent cure; another episode would prompt a fresh symptomatic culture and reassessment of the remaining risk factors.
02Uncomplicated recurrenceSelect proportionate preventionA nonpregnant woman has documented recurrent lower infection without an untreated structural contributor.+
- 1Discuss behavioural and hygiene measures and modifiable triggers, and use vaginal oestrogen when appropriate for peri- or postmenopausal symptoms and prevention. Systemic hormone replacement should not be prescribed solely to prevent UTI.
- 2If there is an identifiable trigger and earlier measures are insufficient or unsuitable, consider a single-dose antibiotic preventive strategy using susceptibility and individual risks. Review benefit and harms rather than assuming a trigger strategy is equivalent to continuous prophylaxis.
- 3AlternativeConsider methenamine hippurate as an alternative to daily antibiotics when applicable earlier measures have not adequately helped and the current UTI has been treated. If prevention remains ineffective, daily antibiotic prophylaxis may be considered after appropriate investigation, with at least six-monthly review.
03Specialist populationsDo not generalise uncomplicated preventionThe patient is pregnant, has male urinary anatomy, upper recurrence or complicated lower infection.+
- 1Seek specialist advice on the cause and prevention plan. Methenamine in pregnancy, male urinary anatomy, recurrent upper UTI or complicated lower UTI needs specialist advice; an uncomplicated adult female prevention recommendation does not automatically apply.
- 2Assess persistent stones, obstruction, devices, prostate infection or a significant emptying disorder and address these where possible. Repeated suppression without source assessment may conceal a continuing contributor.
- 3Agree a plan for new symptomatic episodes, including when to submit a specimen and seek urgent assessment. A preventive drug should never delay treatment of fever, flank pain, sepsis or an infected obstructed system.
05Procedure and medicine safetyRelevant preparation, treatment and contraindications.
Methenamine hippurate 1 g tablets
After treating active UTI and finding applicable behavioural, vaginal oestrogen or trigger measures insufficient or unsuitable, an eligible nonpregnant adult woman can take 1 g orally twice daily; review within six months and then annually.Check the exact Hiprex product contraindications: hepatic dysfunction, renal parenchymal infection, severe dehydration, metabolic acidosis, gout and severe renal failure with clearance or GFR below 10. Avoid sulphonamides because of crystalluria and avoid alkalinising citrate UTI sachets or acetazolamide because they reduce efficacy. Pregnancy and complicated or upper recurrence require specialist advice. Counsel that new acute symptoms still need assessment and treatment; this regimen does not treat sepsis.
06Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Measure prevention success by symptomatic episodes, cultures when clinically indicated, antibiotic use and the patient’s experience, rather than by repeated screening cultures while well.
- Review methenamine at six months and then annually, checking adherence, adverse effects, new renal or hepatic disease and use of over-the-counter urinary alkalinising products.
- Review daily antibiotic prophylaxis at least every six months and discuss continuing, changing or stopping in light of benefit, resistance and adverse effects; keep a plan for rapid access if symptoms return.
- After an intervention for incomplete emptying or another contributor, verify that the targeted problem has improved. Continued infections should trigger a revised diagnostic assessment rather than automatic escalation of prophylaxis.
07Special situationsVariants, exceptions and circumstances that change the usual approach.
A culture is contextual
A well-collected sample during symptoms has a different role from a screening specimen in an asymptomatic person. Antibiotic prescriptions without a compatible clinical syndrome should not be counted automatically as proven recurrent infections.
Investigate the right abnormality
Repeated Proteus or another urease-producing organism can raise suspicion of stone disease, while poor emptying points toward residual assessment. The history helps select the question before a test is ordered.
Vaginal and systemic differ
For appropriate peri- or postmenopausal patients, vaginal oestrogen may help reduce recurrent infection and associated local symptoms. Discuss preparation preference and contraindications; systemic HRT should not be used specifically for UTI prevention.
Prevention has a review date
A preventive medicine is a monitored trial with an outcome and stopping decision, not an indefinite default. Explain expected benefits, uncertainty and the action plan if an acute infection breaks through.
08Common pitfallsFrequent interpretation and management errors.
- 01
Counting every positive urine test as another UTI can create a false recurrence diagnosis and lead to unnecessary long-term medicines.
- 02
Ordering routine cystoscopy for every otherwise typical uncomplicated recurrence adds burden without first identifying a question that the procedure can answer.
- 03
Starting prophylaxis before treating the active infection or investigating a likely obstructive contributor can leave the underlying problem unresolved.
- 04
Combining methenamine with alkalinising UTI sachets undermines its intended urinary activity and may explain an apparent prevention failure.